Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.
about
Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.Docetaxel-associated epiphora.Preclinical pharmacokinetic/pharmacodynamic models to predict schedule-dependent interaction between erlotinib and gemcitabine.Quality of life as an endpoint in Phase I oncology clinical trials of novel chemotherapy drugs.Complete remission of a metastatic pancreatic carcinoma after modified G-FLIP therapy.
P2860
Phase I trial using weekly administration of gemcitabine and docetaxel in patients with advanced pancreatic carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase I trial using weekly adm ...... advanced pancreatic carcinoma.
@en
type
label
Phase I trial using weekly adm ...... advanced pancreatic carcinoma.
@en
prefLabel
Phase I trial using weekly adm ...... advanced pancreatic carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Phase I trial using weekly adm ...... advanced pancreatic carcinoma.
@en
P2093
P2860
P304
P356
10.1159/000082628
P577
2004-12-08T00:00:00Z